91 related articles for article (PubMed ID: 15674351)
1. p53 in human embryonal carcinoma: identification of a transferable, transcriptional repression domain in the N-terminal region of p53.
Curtin JC; Spinella MJ
Oncogene; 2005 Feb; 24(9):1481-90. PubMed ID: 15674351
[TBL] [Abstract][Full Text] [Related]
2. Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function.
Curtin JC; Dragnev KH; Sekula D; Christie AJ; Dmitrovsky E; Spinella MJ
Oncogene; 2001 May; 20(20):2559-69. PubMed ID: 11420666
[TBL] [Abstract][Full Text] [Related]
3. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
[TBL] [Abstract][Full Text] [Related]
4. 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARgamma independent pathway.
Kitareewan S; Spinella MJ; Allopenna J; Reczek PR; Dmitrovsky E
Oncogene; 1999 Oct; 18(42):5747-55. PubMed ID: 10523855
[TBL] [Abstract][Full Text] [Related]
5. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
[TBL] [Abstract][Full Text] [Related]
6. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells.
Moasser MM; Khoo KS; Maerz WJ; Zelenetz A; Dmitrovsky E
Differentiation; 1996 Jul; 60(4):251-7. PubMed ID: 8765055
[TBL] [Abstract][Full Text] [Related]
7. Selective repression of retinoic acid target genes by RIP140 during induced tumor cell differentiation of pluripotent human embryonal carcinoma cells.
Heim KC; White KA; Deng D; Tomlinson CR; Moore JH; Freemantle SJ; Spinella MJ
Mol Cancer; 2007 Sep; 6():57. PubMed ID: 17880687
[TBL] [Abstract][Full Text] [Related]
8. The basic carboxy-terminal domain of human p53 is dispensable for both transcriptional regulation and inhibition of tumor cell growth.
Pellegata NS; Cajot JF; Stanbridge EJ
Oncogene; 1995 Jul; 11(2):337-49. PubMed ID: 7624148
[TBL] [Abstract][Full Text] [Related]
9. Identification of a retinoic acid-inducible element in the murine PTH/PTHrP (parathyroid hormone/parathyroid hormone-related peptide) receptor gene.
Karperien M; Farih-Sips H; Hendriks JA; Lanske B; Papapoulos SE; Abou-Samra AB; Löwik CW; Defize LH
Mol Endocrinol; 1999 Jul; 13(7):1183-96. PubMed ID: 10406468
[TBL] [Abstract][Full Text] [Related]
10. Wnt pathway reprogramming during human embryonal carcinoma differentiation and potential for therapeutic targeting.
Snow GE; Kasper AC; Busch AM; Schwarz E; Ewings KE; Bee T; Spinella MJ; Dmitrovsky E; Freemantle SJ
BMC Cancer; 2009 Oct; 9():383. PubMed ID: 19874621
[TBL] [Abstract][Full Text] [Related]
11. Repression of hepatocyte nuclear factor 4alpha tumor suppressor p53: involvement of the ligand-binding domain and histone deacetylase activity.
Maeda Y; Seidel SD; Wei G; Liu X; Sladek FM
Mol Endocrinol; 2002 Feb; 16(2):402-10. PubMed ID: 11818510
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid represses a cassette of candidate pluripotency chromosome 12p genes during induced loss of human embryonal carcinoma tumorigenicity.
Giuliano CJ; Kerley-Hamilton JS; Bee T; Freemantle SJ; Manickaratnam R; Dmitrovsky E; Spinella MJ
Biochim Biophys Acta; 2005 Oct; 1731(1):48-56. PubMed ID: 16168501
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism.
Loudig O; Babichuk C; White J; Abu-Abed S; Mueller C; Petkovich M
Mol Endocrinol; 2000 Sep; 14(9):1483-97. PubMed ID: 10976925
[TBL] [Abstract][Full Text] [Related]
14. Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor gamma in human teratocarcinomas.
Moasser MM; DeBlasio A; Dmitrovsky E
Oncogene; 1994 Mar; 9(3):833-40. PubMed ID: 8108126
[TBL] [Abstract][Full Text] [Related]
15. Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.
Dreyfus DH; Nagasawa M; Gelfand EW; Ghoda LY
BMC Immunol; 2005 Jun; 6():12. PubMed ID: 15969767
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation.
Spinella MJ; Freemantle SJ; Sekula D; Chang JH; Christie AJ; Dmitrovsky E
J Biol Chem; 1999 Jul; 274(31):22013-8. PubMed ID: 10419526
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid receptor gamma activates receptor tyrosine kinase Tie1 gene transcription through transcription factor GATA4 in F9 stem cells.
Su D; Gudas LJ
Exp Hematol; 2008 May; 36(5):624-41. PubMed ID: 18439490
[TBL] [Abstract][Full Text] [Related]
18. Repression of cyclin D1 as a target for germ cell tumors.
Freemantle SJ; Vaseva AV; Ewings KE; Bee T; Krizan KA; Kelley MR; Hattab EM; Memoli VA; Black CC; Spinella MJ; Dmitrovsky E
Int J Oncol; 2007 Feb; 30(2):333-40. PubMed ID: 17203214
[TBL] [Abstract][Full Text] [Related]
19. Loss of transactivation and transrepression function, and not RPA binding, alters growth suppression by p53.
Leiter LM; Chen J; Marathe T; Tanaka M; Dutta A
Oncogene; 1996 Jun; 12(12):2661-8. PubMed ID: 8700525
[TBL] [Abstract][Full Text] [Related]
20. Constitutive gene expression predisposes morphogen-mediated cell fate responses of NT2/D1 and 27X-1 human embryonal carcinoma cells.
Chadalavada RS; Korkola JE; Houldsworth J; Olshen AB; Bosl GJ; Studer L; Chaganti RS
Stem Cells; 2007 Mar; 25(3):771-8. PubMed ID: 17138961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
